Condition
Idiopathic Hypercalciuria
Total Trials
4
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Completed4
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06681116Not ApplicableCompleted
Use of Nanotechnology Structured Water for the Prevention of Recurrent Stone Formation
NCT02830009Not ApplicableCompleted
IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
NCT01295879Phase 4Completed
Vitamin D Repletion in Stone Formers With Hypercalciuria
NCT00276289Not ApplicableCompletedPrimary
Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
Showing all 4 trials